xTAG Cystic Fibrosis 39 Kit v2
Screens recommended mutations and variants
The xTAG® Cystic Fibrosis 39 Kit v2, from Luminex, Austin, Tex, screens for the 23 CFTR gene mutations and four variants recommended by the American College of Medical Genetics and American College of Obstetricians and Gynecologists, and 16 additional CFTR gene mutations from human blood specimens in a few hours. It is used to screen potential parents to determine if they are carriers of CF-causing gene mutations, and as an aid in newborn screening and in confirmatory diagnostic testing in newborns and children. The test is uniquely flexible, offering physicians the option to test for the 23 ACMG/ACOG-recommended gene mutations or the entire panel of 39 CFTR gene mutations.
Fetal maternal hemorrhage screening test
Ortho Clinical Diagnostics, Rochester, NY, introduces the FETALSCREEN™ II—a simple, qualitative test that detects D (Rho) positive fetal red blood cells in the maternal circulation of pregnant Rh-negative women. The test is an important screening component for the detection, prevention, and management of Hemolytic Disease of the Newborn. The test uses an innovative blend of monoclonal antibodies for stability and accuracy, enzyme-treated indicator cells to facilitate robust reactivity and results clarity, and fewer microscopic fields to simplify results reading and interpretation. The test can be performed in both hospitals and blood banks.
Ortho Clinical Diagnostics
Sensitive early pregnancy detection
The QuickVue One-Step hCG Urine and QuickVue One-Step Combo tests, from Quidel, San Diego, are sensitive immunoassays for the qualitative detection of human Chorionic gonadotropin (hCG) in urine for the early detection of pregnancy. The QuickVue+ One-Step hCG Combo test uses a monoclonal antibody specific to the beta subunit of hCG in a single-step technology to accurately detect hCG.
Clearview hCG Line
With >99% sensitivity for early pregnancy detection
The Clearview® hCG line, from Inverness Medical, Princeton, NJ, offers four different product formats for early diagnosis of pregnancy: Clearview hCG Urine Dipstick, Clearview hCG Urine Cassette, Clearview hCG Combo II, and Clearview 25 hCG Combo. All Clearview hCG test kits provide >99% sensitive and specific results for human Chorionic gonadotropin (HCG), the pregnancy hormone, in urine or serum samples. Single-step procedures can provide positive results in as little as 1 minute. The tests are CLIA waived for urine, and built-in controls ensure accuracy. With sensitivities from 10 to 25 mIU/mL, the tests also offer room-temperature storage and a 24-month shelf life from date of manufacture.
QIAamp Circulating Nucleic Acid Kit
Enables the isolation and purification of nucleic acids
QIAGEN, Germantown, Md, introduces its QIAamp circulating nucleic acid kit for the extraction of free circulating fragments of tumor- and fetal-derived nucleic acids and viral nucleic acids in human blood. The kit, which enables the isolation and purification of all types and sizes of nucleic acids, is currently available for research use only. The company plans to validate the product for in vitro diagnostic applications in the United States and Europe.